losartan has been researched along with pyrimidinones in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ciccocioppo, R; Cirillo, R; Massi, M; Polidori, C; Pompei, P | 2 |
| Catalioto, RM; Criscuoli, M; Giachetti, A; Porchia, R; Renzetti, AR; Subissi, A | 1 |
| Audus, KL; Proudfoot, J; Yazdanian, M; Young, AM | 1 |
| Chi, YH; Kim, JH; Kim, TW; Lee, JK; Lee, JY; Lee, KT; Yoo, BW | 1 |
| Chen, DQ; Chen, H; Chen, L; Dou, F; Liu, D; Vaziri, ND; Wang, M; Zhao, YY | 1 |
6 other study(ies) available for losartan and pyrimidinones
| Article | Year |
|---|---|
The selective angiotensin AT1 receptor antagonist LR-B/081 potently inhibits drinking induced by central injection of angiotensin II in rats.
Topics: Analysis of Variance; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Biphenyl Compounds; Carbachol; Dose-Response Relationship, Drug; Drinking; Eating; Imidazoles; Injections, Intraventricular; Lethal Dose 50; Losartan; Male; Milk; Pyrimidinones; Rats; Rats, Wistar; Renin-Angiotensin System; Tetrazoles; Thiophenes | 1995 |
Angiotensin II-induced responses in vascular smooth muscle cells: inhibition by non-peptide receptor antagonists.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Aorta, Thoracic; Biphenyl Compounds; Cells, Cultured; Dinoprostone; DNA; Epoprostenol; Imidazoles; Inositol 1,4,5-Trisphosphate; Leucine; Losartan; Male; Muscle, Smooth, Vascular; Protein Biosynthesis; Pyridines; Pyrimidinones; Rats; Rats, Sprague-Dawley; Tetrazoles; Thiophenes; Thymidine | 1995 |
Functional evidence for the ability of angiotensin AT1 receptor antagonists to cross the blood-brain barrier in rats.
Topics: Administration, Oral; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Blood-Brain Barrier; Carbachol; Dose-Response Relationship, Drug; Drinking; Imidazoles; Injections, Intraperitoneal; Injections, Intraventricular; Losartan; Male; Nicotinic Acids; Pyrimidinones; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Tetrazoles; Thiophenes | 1996 |
Tetrazole compounds: the effect of structure and pH on Caco-2 cell permeability.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzimidazoles; Caco-2 Cells; Cell Line; Cell Membrane Permeability; Cell Polarity; Dogs; Drug Design; Humans; Hydrogen-Ion Concentration; Losartan; Membrane Transport Proteins; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Pyridines; Pyrimidinones; Structure-Activity Relationship; Tetrazoles; Transfection | 2006 |
Synthesis and antihypertensive activity of pyrimidin-4(3H)-one derivatives as losartan analogue for new angiotensin II receptor type 1 (AT1) antagonists.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Inhibitory Concentration 50; Losartan; Molecular Structure; Protein Binding; Pyrimidinones; Rats | 2012 |
Role of RAS/Wnt/β-catenin axis activation in the pathogenesis of podocyte injury and tubulo-interstitial nephropathy.
Topics: Angiotensin II; beta Catenin; Bridged Bicyclo Compounds, Heterocyclic; Cells, Cultured; Dose-Response Relationship, Drug; Humans; Kidney Tubules; Losartan; Nephritis, Interstitial; Podocytes; Pyrimidinones; Renin-Angiotensin System; Structure-Activity Relationship; Wnt Proteins | 2017 |